These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21749303)

  • 1. White matter hyperintensities: from medical comorbidities to bipolar disorders and back.
    Gunde E; Blagdon R; Hajek T
    Ann Med; 2011 Dec; 43(8):571-80. PubMed ID: 21749303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities, suicide risk and late-onset affective disorders: an overview of the current literature.
    Pompili M; Serafini G; Innamorati M; Serra G; Forte A; Lester D; Ducci G; Girardi P; Tatarelli R
    Clin Ter; 2010; 161(6):555-63. PubMed ID: 21181087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities in young individuals with bipolar disorder or at high genetic risk.
    Wadhwa R; Wen W; Frankland A; Leung V; Sinbandhit C; Stuart A; Dawes L; Hadzi-Pavlovic D; Levy F; Lenrootl R; Mitchell PB; Roberts G
    J Affect Disord; 2019 Feb; 245():228-236. PubMed ID: 30412775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine.
    Su Y; Tay VQ; Singh S; Leary MC; Koss V; Kincaid HM; Yacoub HA; Castaldo J
    Headache; 2024 Jun; 64(6):612-623. PubMed ID: 38785411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of periventricular white matter lesions in patients with bipolar disorder type I.
    Serafini G; Pompili M; Innamorati M; Girardi N; Strusi L; Amore M; Sher L; Gonda X; Rihmer Z; Girardi P
    CNS Spectr; 2016 Feb; 21(1):23-34. PubMed ID: 24411553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of white matter damage in late onset bipolar disorder.
    Besga A; Martinez-Cengotitabengoa M; González-Ortega I; Gutierrez M; Barbeito S; Gonzalez-Pinto A
    Maturitas; 2011 Oct; 70(2):160-3. PubMed ID: 21872409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased rates of white matter hyperintensities in late-onset bipolar disorder.
    Tamashiro JH; Zung S; Zanetti MV; de Castro CC; Vallada H; Busatto GF; de Toledo Ferraz Alves TC
    Bipolar Disord; 2008 Nov; 10(7):765-75. PubMed ID: 19032708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of MRI-defined vascular depression: A longitudinal, community-based study in Korean elders.
    Park JH; Lee SB; Lee JJ; Yoon JC; Han JW; Kim TH; Jeong HG; Newhouse PA; Taylor WD; Kim JH; Woo JI; Kim KW
    J Affect Disord; 2015 Jul; 180():200-6. PubMed ID: 25913805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients.
    Regenold WT; Hisley KC; Phatak P; Marano CM; Obuchowski A; Lefkowitz DM; Sassan A; Ohri S; Phillips TL; Dosanjh N; Conley RR; Gullapalli R
    Bipolar Disord; 2008 Nov; 10(7):753-64. PubMed ID: 19032707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities.
    Prieto ML; Ryu E; Jenkins GD; Batzler A; Nassan MM; Cuellar-Barboza AB; Pathak J; McElroy SL; Frye MA; Biernacka JM
    Transl Psychiatry; 2016 Aug; 6(8):e870. PubMed ID: 27529678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter pathology--an endophenotype for bipolar disorder?
    Borgwardt S; Fusar-Poli P
    BMC Psychiatry; 2012 Sep; 12():138. PubMed ID: 22970986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: a two-center high-risk study.
    Gunde E; Novak T; Kopecek M; Schmidt M; Propper L; Stopkova P; Höschl C; Duffy A; Alda M; Hajek T
    J Psychiatr Res; 2011 Jan; 45(1):76-82. PubMed ID: 20488462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of white matter hyperintensities in migraine patients.
    Al-Hashel JY; Alroughani R; Gad K; Al-Sarraf L; Ahmed SF
    BMC Neurol; 2022 Apr; 22(1):159. PubMed ID: 35488255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases.
    Perugi G; Quaranta G; Belletti S; Casalini F; Mosti N; Toni C; Dell'Osso L
    J Affect Disord; 2015 Jan; 170():95-103. PubMed ID: 25237732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of white matter hyperintensities with migraine features and prognosis.
    Xie H; Zhang Q; Huo K; Liu R; Jian ZJ; Bian YT; Li GL; Zhu D; Zhang LH; Yang J; Luo GG
    BMC Neurol; 2018 Jul; 18(1):93. PubMed ID: 29966519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life.
    Carta MG; Moro MF; Lorefice L; Picardi A; Trincas G; Fenu G; Cocco E; Floris F; Bessonov D; Akiskal HS; Marrosu MG
    J Affect Disord; 2014; 167():192-7. PubMed ID: 24995886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
    Gladstone JP; Dodick DW
    Neurologist; 2005 Jan; 11(1):19-29. PubMed ID: 15631641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
    Regenold WT; Hisley KC; Obuchowski A; Lefkowitz DM; Marano C; Hauser P
    J Affect Disord; 2005 Apr; 85(3):341-50. PubMed ID: 15780705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: a systematic review.
    Fornaro M; De Berardis D; De Pasquale C; Indelicato L; Pollice R; Valchera A; Perna G; Iasevoli F; Tomasetti C; Martinotti G; Koshy AS; Fasmer OB; Oedegaard KJ
    Compr Psychiatry; 2015 Jan; 56():1-16. PubMed ID: 25306379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-morbidity of bipolar disorder and borderline personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    McDermid J; Sareen J; El-Gabalawy R; Pagura J; Spiwak R; Enns MW
    Compr Psychiatry; 2015 Apr; 58():18-28. PubMed ID: 25666748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.